The PPA holds some of the information you requested on 21 July 2005, namely information about how many generic versions are available, though we can not guarantee that this is a comprehensive list. The data only applies to England. A copy of the information we do hold is enclosed. Captopril 12.5mg tablets - 10 versions Captopril 25mg tablets - 11 versions Captopril 50mg tablets - 9 versions Please note the following caveats on the data: - this list is not inclusive of all generic manufacturers / suppliers of Captopril - for reimbursement 'supplier' may be a manufacturer or wholesaler - any products discontinued prior to 2002 may not be included - there are other proprietary brands of Captopril, other than Capoten. No 'brands' have been included in this search As part of my duty to advise and assist, may I draw your attention to the Department of Health?s web-site, the address of which is (http://www.publications.doh. gov.uk/prescriptionstatistics/index.htm), in particular the Prescription Cost Analysis reports listed there, where data related to drug use at national level is available. The information supplied to you continues to be protected by the Copyright, Designs and Patents Act 1988. You are free to use it for your own purposes, including any non-commercial research you are doing and for the purposes of news reporting. Any other re-use, for example commercial publication, would require the permission of the copyright holder. Most documents supplied by the Prescription Pricing Authority will have been produced by government officials and will be Crown Copyright. You can find details on the arrangements for re-using Crown Copyright on HMSOnline at: http://www.hmso.gov.uk/copyright/licences/click-use-home.htm Information you receive which is not subject to Crown Copyright continues to be protected by the copyright of the person, or organisation, from which the information originated. You must ensure that you gain their permission before reproducing any third party (non Crown Copyright) information. This information provided is based on our understanding of your request and is provided solely to meet your request. The information should therefore not be regarded as suitable to be used or relied upon by any person or organisation for any purpose or in any context. Any person or organisation who obtains access to the information and chooses to rely on the information will do so at their own risk. The PPA accepts no responsibility for subsequent use of the information provided.